Timing Strategies of Direct-Acting Antivirals and Biologics Administration in HCV-Infected Subjects with Inflammatory Bowel Diseases

Timing Strategies of Direct-Acting Antivirals and Biologics Administration in HCV-Infected Subjects with Inflammatory Bowel Diseases

Background: In the last years, inflammatory bowel disease (IBD) and hepatitis C virus (HCV) infection management has completely changed. However, the role of direct-acting antivirals (DAAs) and the correct timing of antiviral drugs administration in IBD patients needing biologics has not been evalua...

Full description

Bibliographic Details
Main Authors: Nicola Imperatore, Fabiana Castiglione, Antonio Rispo, Anna Sessa, Nicola Caporaso, Filomena Morisco
Format: Article
Language:English
Published: Frontiers Media S.A. 2017-11-01
Series:Frontiers in Pharmacology
Subjects:
inflammatory bowel diseases
hepatitis C virus infection
direct-acting antivirals
biologics
drug-to-drug interaction
Online Access:http://journal.frontiersin.org/article/10.3389/fphar.2017.00867/full

Internet

http://journal.frontiersin.org/article/10.3389/fphar.2017.00867/full

Similar Items